Xbrane Biopharma Ab operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Xbrane Biopharma Ab with three other
companies in this sector in Sweden:
sales of 23.86 million Swedish Kronor [US$2.50 million]
of which 100%
Sprint Bioscience AB
(17.94 million Swedish Kronor [US$1.88 million]
Active Biotech AB
(20.05 million Swedish Kronor [US$2.10 million]
of which 80%
was Rental revenues).
Xbrane Biopharma Ab reported sales of SEK 20.49 million (US$2.15 million)
December of 2018.
decrease of 1.4%
versus 2017, when the company's sales were SEK 20.77 million.